INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio/Video recording of Conference organised by Dolat Capital Market Private Limited21-02-2023
21-02-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In continuation to our letter dated 02nd February, 2023 regarding intimation of schedule of investor calls and pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), the Audio/Video recording of the Investors Conference Call organised by Nirmal Bang on 13th February, 2023 is available on the Company's website at https://www.indoco.com/inv-investor-analysts-meetings.asp14-02-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing schedule for the Investor Call/ Institutional Investors Conference/Meetings.03-02-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing schedule for the Investor Call/ Institutional Investors Conference/Meetings.02-02-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Conference Call for the quarter and nine months ended 31st December, 202231-01-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 202225-01-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Audio recording of earnings conference call for the quarter and nine months ended 31st December, 202225-01-2023
Indoco Remedies Results Earnings Call for Q3FY23
Conference Call with Indoco Remedies Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.24-01-2023
INDOCO REMEDIES LTD. - 532612 - Intimation Of Grant Of Stock Options And Restricted Stock Units Under Indoco Remedies Limited Employee Stock Option Plan - 2022
In accordance with the provisions of the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we hereby inform you that a meeting of the Nomination and Remuneration Committee of Indoco Remedies Limited (the 'Company') was held today i.e. 24th January, 2023 for grant of 2,95,500 Employee Stock Options ('Options') and 75,000 Restricted Stock Unit ('RSUs') to its eligible employees convertible into equal number of Equity Shares of the Company of face value of Rs. 2/- each, under the Indoco Remedies Limited Employee Stock Option Plan - 2022 ('Plan').24-01-2023